Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
anxiety
Biotech
Karuna's captains set sail in new neuropsychiatric biotech
Just months after Bristol Myers Squibb boarded Karuna for its much-hyped schizophrenia drug, the biotech’s leadership has set sail in a new venture.
James Waldron
Apr 9, 2024 8:25am
Neuropsych biotech Engrail closes $157M series B
Mar 19, 2024 8:00am
FDA accepts first AI algorithm to drug development tool pilot
Jan 26, 2024 1:35pm
MindMed links LSD to reduced anxiety in phase 2b, plots phase 3
Dec 14, 2023 9:32am
Bionomics' midphase PTSD clinical trial hits primary endpoint
Sep 28, 2023 7:08am
Relmada's depression med bounces back in open-label trial
Sep 20, 2023 11:00am